2026-05-08
Insight Velocity: The Governance of Real-Time Medical Signal Detection
How executive leadership teams leverage proprietary infrastructure to identify competitive shifts 18 months before market recognition.
Read briefMeddash Insights
Decision-ready perspectives for medical affairs and biotech teams.
2026-05-08
Network Centrality in Medical Affairs: Beyond the Visible Tier
Why structural network position outperforms visibility metrics for identifying high-value experts before competitive awareness develops.
Read brief2026-05-07
Mapping Clinical Trial Catalyst Events: Beyond the PDUFA Date
How Medical Affairs teams leverage multi-dimensional signal detection to identify strategic windows 6-18 months before regulatory milestones.
Read brief2026-04-30
KOL Identification Framework for Early-Stage Biotech
A practical KOL identification framework for early-stage biotech teams that need fast, decision-ready expert mapping.
Read brief2026-04-30
How to Track Biotech Catalysts Without Signal Overload
A signal-first method to track biotech catalysts across FDA, SEC, and clinical milestones without dashboard fatigue.
Read brief2026-04-30
Clinical Trial Search Workflow for Medical Affairs Teams
A repeatable clinical trial search workflow for medical affairs teams that need faster landscape clarity and KOL alignment.
Read brief2026-05-02
KOL Identification Platform for Biotech: How to Find Key Opinion Leaders in 48 Hours
Most biotech teams spend three weeks identifying key opinion leaders. MedDash reduces KOL identification to 48 hours with a 3D KOL map, not a spreadsheet.
Read brief2026-05-02
Oncology KOL Identification: How to Find Key Opinion Leaders in Oncology in 48 Hours
Oncology is the most crowded therapeutic area in biotech. MedDash identifies oncology KOLs in 48 hours with a 3D KOL map built for the speed of cancer drug development.
Read brief